Skip to main content
Apontis Pharma AG (FRA:APPH)
Germany flag Germany · Delayed Price · Currency is EUR
11.05
+0.20 (1.84%)
Last updated: May 13, 2025

Revenue by Product

Fiscal year is January - December.
Year Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Single Pills - Hypertension
25.64M
Log In
Log In
Log In
Log In
Single Pills - Hypertension Growth
-29.84%
Log In
Log In
Log In
Log In
Co-Marketing - CO PD (Respiratory Diseases)
7.96M
Log In
Log In
Log In
Log In
Co-Marketing - CO PD (Respiratory Diseases) Growth
-20.21%
Log In
Log In
Log In
Log In
Corporate Brands (without Single Pills) - Other
2.05M
Log In
Log In
Log In
Log In
Corporate Brands (without Single Pills) - Other Growth
-3.07%
Log In
Log In
Log In
Log In
Co-Marketing - Cardiovascular
1.13M
Log In
Log In
Log In
Log In
Co-Marketing - Diabetes
175.00K
Log In
Log In
Log In
Log In
Co-Marketing - Diabetes Growth
-97.44%
Log In
Log In
Log In
Log In
Corporate Brands (without Single Pills) - Gynecology
-
Log In
Log In
Log In
Log In
Corporate Brands (without Single Pills) - Gynecology Growth
-
Log In
Log In
Log In
Log In
Corporate Brands (without Single Pills) - Vascular
-
Log In
Log In
Log In
Log In
Corporate Brands (without Single Pills) - Vascular Growth
-
Log In
Log In
Log In
Log In
Dafiro
-
Log In
Log In
Log In
Log In
Dafiro Growth
-
Log In
Log In
Log In
Log In
Corporate Brands (without Single Pills) - Arthritis
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Year Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Germany
36.96M
Log In
Log In
Log In
Log In
Germany Growth
-33.67%
Log In
Log In
Log In
Log In